BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30878446)

  • 1. Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention.
    Rao J; Mei L; Liu J; Tang X; Yin S; Xia C; Wei J; Wan D; Wang X; Wang Y; Li M; Zhang Z; He Q
    Acta Biomater; 2019 Apr; 89():300-312. PubMed ID: 30878446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
    Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
    Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
    Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bubble-generating polymersomes loaded with both indocyanine green and doxorubicin for effective chemotherapy combined with photothermal therapy.
    Zhu D; Fan F; Huang C; Zhang Z; Qin Y; Lu L; Wang H; Jin X; Zhao H; Yang H; Zhang C; Yang J; Liu Z; Sun H; Leng X; Kong D; Zhang L
    Acta Biomater; 2018 Jul; 75():386-397. PubMed ID: 29793073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
    Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
    Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering folate-targeting diselenide-containing triblock copolymer as a redox-responsive shell-sheddable micelle for antitumor therapy in vivo.
    Behroozi F; Abdkhodaie MJ; Abandansari HS; Satarian L; Molazem M; Al-Jamal KT; Baharvand H
    Acta Biomater; 2018 Aug; 76():239-256. PubMed ID: 29928995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
    Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
    Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.
    Wan Z; Sun J; Xu J; Moharil P; Chen J; Xu J; Zhu J; Li J; Huang Y; Xu P; Ma X; Xie W; Lu B; Li S
    Acta Biomater; 2019 May; 90():300-313. PubMed ID: 30930305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression.
    Banala VT; Urandur S; Sharma S; Sharma M; Shukla RP; Marwaha D; Gautam S; Dwivedi M; Mishra PR
    Biomater Sci; 2019 Jun; 7(7):2889-2906. PubMed ID: 31086900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
    Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
    Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
    Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
    Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment.
    Hu G; Chun X; Wang Y; He Q; Gao H
    Oncotarget; 2015 Dec; 6(38):41258-74. PubMed ID: 26517810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy.
    Cheng X; Zeng X; Zheng Y; Fang Q; Wang X; Wang J; Tang R
    J Colloid Interface Sci; 2020 Apr; 565():254-269. PubMed ID: 31978788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
    Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
    Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy.
    Saiyin W; Wang D; Li L; Zhu L; Liu B; Sheng L; Li Y; Zhu B; Mao L; Li G; Zhu X
    Mol Pharm; 2014 May; 11(5):1662-75. PubMed ID: 24666011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
    Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R
    Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment of the primary tumor and lymph node metastasis by polymeric micelles with variable particle sizes.
    Mei L; Rao J; Liu Y; Li M; Zhang Z; He Q
    J Control Release; 2018 Dec; 292():67-77. PubMed ID: 29723611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bio-responsive 6-mercaptopurine/doxorubicin based "Click Chemistry" polymeric prodrug for cancer therapy.
    Liao J; Peng H; Wei X; Song Y; Liu C; Li D; Yin Y; Xiong X; Zheng H; Wang Q
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110461. PubMed ID: 31924029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin and rhein loaded nanomicelles attenuates multidrug resistance in human ovarian cancer.
    Han NN; Li X; Tao L; Zhou Q
    Biochem Biophys Res Commun; 2018 Mar; 498(1):178-185. PubMed ID: 29317204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.